The 18th Annual Non-Dilutive Funding Summit

The 18th Non-Dilutive Funding Summit brought together hundreds of life science industry leaders with directors at ARPA-H, BARDA, SEED, NIA, NHLBI, NIAID, NINDS, and CIRM, so the innovators could learn about non-dilutive funding opportunities for their R&D directly from the funding agencies.

This free summit is hosted by the FreeMind Group. FreeMind helps companies secure non-dilutive funding for life science R&D and wins over $100 million each year for clients. Follow us on LinkedIn or get our newsletter for news about non-dilutive funding opportunities, announcements about conferences with the best partnering, and discounts for those conferences. The 19th Non-Dilutive Funding Summit will be January 10, 2024.

Funding & Product Development Resources for Heart, Lung, Blood, & Sleep Technologies

The National Heart, Lung, and Blood Institute (NHLBI)

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives. The NHLBI is interested in Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) activities that advance the prevention, diagnosis, and treatment of heart, lung, blood, and sleep disorders.

Dr. Kathleen Rousche

Dr. Kathleen Rousche serves as the Director of the Innovation and Commercialization Office within the Division of Extramural Research Activities at the National Heart Lung and Blood Institute of the National Institutes of Health. In this role, Dr. Rousche oversees activities designed to help innovators in academia and industry translate new and promising discoveries into biomedical products that prevent, diagnose, and treat heart, lung, blood, and sleep diseases and disorders.

Dr. Rousche’s office coordinates and serves as a central point of contact for the NHLBI Small Business Programs (SBIR/STTR) and supports translational research initiatives directed at advancing promising technologies to the marketplace. Services offered to innovators include pre-application advice, entrepreneurial education, product and business development resources during funding periods, and access to potential federal and private sector partners that may support further technology development, to more efficiently and effectively move discoveries to benefit public health.

Dr. Rousche has a diverse background in translational biomedical research, program administration, teaching, and alliance and project management. She worked in industry, academia, and medical communications prior to joining the NIH.

Reserve Your Place Today

Register Now Free of Charge
For the 19th Annual Non-Dilutive Funding Summit (NDFS)
Wednesday, January 10, 2024
To Join Hundreds of Life Science Industry Leaders
In Learning about Non-Dilutive Funding Opportunities for Your R&D.

Speakers, location, and all other details to be announced.
Register now to receive updates.

Follow us on LinkedIn or request our newsletter to receive:

  • News about non-dilutive funding opportunities
  • Announcements about conferences with the best partnering for life science professionals
  • Discounts for those conferences.